Navigation
banner
Together we Drive the Future

Antibody & Protein Therapeutics Summit

2017-02-212017-06-112017-05-11
EARLY BIRD DISCOUNT! Register by May 11, 2017 to receive 20% off your registration!
Or register 3 for the price of 2 with the coupon code rcdvb!


registration button

Antibody & Protein Therapeutics Summit


Antibodies in Oncology & Infectious Diseases

Antibody Drug Conjugates

Novel Protein Therapeutics
 
 

Dear Colleague,

We invite you to attend the Antibody & Protein Therapeutics Summit to be held on July 11-12, 2017 in Baltimore, MD. The Protein Therapeutics Summit is the ideal venue to network with your fellow researchers, providing access to over 125 presentations from leading industrial and academic experts and will feature research findings, case studies, and technology advancements.

This summit will discuss various areas in the field of protein science. New updates will be given in areas such as protein-protein interactions in drug designs, advances in antibody drug conjugates, bispecific and multispecific antibodies, the expression of difficult proteins, and the purification and characterization of proteins. Don’t miss important insights on how to overcome the many hurdles that are associated with the production of proteins.

The Antibody & Protein Therapeutics Summit will answer exciting key questions for the successful development of new drugs and targeted kinase signaling. Join this multi-disciplinary forum and network with colleagues from industry and academia to discuss the methods and tools that will ensure the most efficient and accurate optimization of proteins.

We hope to see you there!   

Best regards,

The 2017 Advisory Committee

 

2017 Program Director
Victor-Jeffrey Leyton, Université de Sherbrooke
2017 Advisory Board Members
Neeraj Agrawal, Amgen
Ahuva Nissim, Queen Mary University
Amandeep Gakhal, Sutro Biopharma
Ann White, University of Southampton
Bill Harriman , Crystal Bioscience
Birgit Schoeberl, Merrimack Pharmaceuticals
Elad Firnberg, Revolve Biotechnologies
Ernesto Freire, Johns Hopkins University
Nicolas Fischer, Novimmune SA
Gregory Adams, Eleven Biotherapeutics
Janos Luka, Walter Reed Army Institute of Research
Matthew Robinson, Immunome, Inc
Michael R. Dyson, IONTAS Ltd
Andreas Pahl, Heidelberg Pharma
Pedro Berraondo López, CIMA, University of Navarra
Darren Schofield, MedImmune
Seema Kumar, EMD Serono
Jamshid Tanha, University of Ottawa
Thomas Pillow, Genentech
Medha J. Tomlinson, Abbvie
Yan Chen, Genentech